AU2020903051A0 - Compounds, compositions and uses thereof - Google Patents

Compounds, compositions and uses thereof

Info

Publication number
AU2020903051A0
AU2020903051A0 AU2020903051A AU2020903051A AU2020903051A0 AU 2020903051 A0 AU2020903051 A0 AU 2020903051A0 AU 2020903051 A AU2020903051 A AU 2020903051A AU 2020903051 A AU2020903051 A AU 2020903051A AU 2020903051 A0 AU2020903051 A0 AU 2020903051A0
Authority
AU
Australia
Prior art keywords
compositions
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020903051A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COVIRIX Medical Pty Ltd
Original Assignee
COVIRIX Medical Pty Ltd
Filing date
Publication date
Application filed by COVIRIX Medical Pty Ltd filed Critical COVIRIX Medical Pty Ltd
Publication of AU2020903051A0 publication Critical patent/AU2020903051A0/en
Priority to US18/022,840 priority Critical patent/US20240016786A1/en
Priority to JP2023513877A priority patent/JP2023540259A/en
Priority to AU2021332085A priority patent/AU2021332085B2/en
Priority to EP21859409.1A priority patent/EP4203954A1/en
Priority to PCT/AU2021/050978 priority patent/WO2022040741A1/en
Priority to CN202180072511.2A priority patent/CN116419754A/en
Pending legal-status Critical Current

Links

AU2020903051A 2020-08-26 2020-08-26 Compounds, compositions and uses thereof Pending AU2020903051A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US18/022,840 US20240016786A1 (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of pulmonary infections
JP2023513877A JP2023540259A (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of lung infections
AU2021332085A AU2021332085B2 (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of pulmonary infections
EP21859409.1A EP4203954A1 (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of pulmonary infections
PCT/AU2021/050978 WO2022040741A1 (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of pulmonary infections
CN202180072511.2A CN116419754A (en) 2020-08-26 2021-08-25 Glucosidase inhibitors for the treatment and prevention of pulmonary infections

Publications (1)

Publication Number Publication Date
AU2020903051A0 true AU2020903051A0 (en) 2020-09-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP3923935A4 (en) Compounds, compositions and methods
EP4148096A4 (en) Composition
EP3924341A4 (en) Compounds, compositions and methods
EP4132529A4 (en) Compounds and uses thereof
EP4096664A4 (en) Compounds and uses thereof
EP4096667A4 (en) Compounds and uses thereof
EP3990618A4 (en) Hdac6-activated macrophages, compositions, and uses thereof
EP3880194A4 (en) Deuterated compounds, compositions, and uses
EP4096651A4 (en) Compounds and uses thereof
EP4097096A4 (en) Compounds and uses thereof
EP4096668A4 (en) Compounds and uses thereof
EP4223759A4 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
EP4094582A4 (en) Composition
EP3953348A4 (en) Compounds, compositions and methods
EP3911324A4 (en) 1,8-naphthyridinone compounds and uses thereof
AU2022265474A9 (en) Composition
EP4181941A4 (en) Compositions and uses thereof
EP4135753A4 (en) Methods, compositions and uses thereof for reversing sacropenia
EP4161659A4 (en) Modified semaphorin 3a, compositions comprising the same and uses thereof
AU2021901646A0 (en) Compounds, compositions and uses thereof
AU2020903051A0 (en) Compounds, compositions and uses thereof
AU2021378438A9 (en) Imidazothiazole compounds, pharmaceutical compositions, and uses thereof
EP4223850A4 (en) Composition
AU2021374231A9 (en) Composition
EP4230692A4 (en) Composition